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The occurrence of thrombocytopenia, platelet-leukocyte thrombi, intravascu- 
lar deposition of fibrin, and thrombosis of small blood vessels during the evolu- 
tion of the generalized Shwartzman reaction after spaced injections of bacterial 
endotoxins has directed attention to the effects of endotoxins on blood coagula- 
tion. 
McKay, Shapiro, and Shanberge (1) demonstrated that incubation of whole blood 
or plasma with endotoxin resulted in a  shortening of the clotting time in siliconized 
glassware due to an interaction of endotoxin and coagulation  factors at some point 
prior to formation of blood thromboplastin. Robbins and Stetson  (2)  also  observed 
that endotoxin accelerated coagulation in vitro, confirmed  the suggestion  of McKay 
and associates that platelets were necessary for this effect,  and demonstrated  that 
antigen-antibody  reactions  had  entirely  similar  coagulation-accelerating  effects  in 
vitro. In addition, Robbins and Stetson (2) suggested that the endotoxin effect might 
be the result of an interaction between endotoxin and naturally occurring antibodies 
present in rabbit blood. 
Previous studies from this laboratory have shown that incubation of platelet-rich 
rabbit plasma with endotoxin results in an increase  in the activity of platelet factor 
3, a thromboplastin precursor, and the transfer of serotonin and bactericidins against 
Bacillus subtilis from platelets to plasma (3). Platelet factor 3 is a platelet component 
which  reacts with product I  in the presence of factor V and calcium to form blood 
thromboplastin (4). The increased  activity of platelet factor 3 provides at least one 
possible explanation of the in vitro effects  of bacterial endotoxins on coagulation, but 
this observation does not exclude alterations in other coagulation factors. 
The present studies have examined in detail the effects of endotoxin on blood 
coagulation in  vitro  and  have failed to implicate participation  of coagulation 
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factors other than platelet factor 3. Moreover, evidence has been obtained that 
a  transfer of platelet factor 3 from platelets to plasma can be demonstrated in 
vivo after injection of endotoxin intravenously in rabbits. 
Materials and Methods 
Methods for Processing Blood Specimens.--AU glassware was sillconized by immersion in 
a 1:1000 dilution of Dow Coming Z4141 for 1 hour and was baked for 2 hours at 170°C prior 
to use. Rabbit blood for in vitro experiments was obtained by cardiac puncture and was de- 
livered through polyethylene tubing into one-tenth volume  of 3.8 per cent sodium  citrate 
solution.  Blood for in vivo studies was obtained through polyethylene catheters previously 
positioned in the carotid artery. Catheters were throughly rinsed with saline solution between 
collections. 
Platelet-rich  plasma (PRP) was prepared by slow speed (100  g) centrifugation  for 10  min- 
utes  and platelet-poor  plasma (PPP) was obtained  by centrifugation  at  high speed (39,000  g) 
for 30 minutes. PRP contained 300,000 to 600,000  platelets  per mm s  and PPP was free  of 
platelets  under phase microscopy. Blood and plasma samples were centrifuged  at 4°C and 
were kept in an ice  bath prior  to use.  In certain  experiments,  mixtures of PRP and endo- 
toxin  were  incubated at  37°C in  a standard bacteriology  incubator  or  at  4°C in  a refrigerator, 
and during incubation were constantly  rotated at 15 RP~ on a motor-driven Spinnerctte 
(Model ST, New Brunswick Scientific  Co.,  New Brunswick, New Jersey). 
Reagents.--An Eschcr~h~ coli  cndotoxin of the Boivin type (Difco,  Lot 0127:B8) sus- 
pended in saline  solution  to a concentration  of 2 mg per ml was used in all experiments. 
Diatomaceous silica  was obtained as fllter-cel  from Johns-Manville (Lampoc, California). 
Poliomyelitis  immune globulin  (Lederle  Laboratories  Division,  American Cyanamid Com- 
pany, Pearl  River,  New York) was used  as a source of human  gamma  globulin.  Anti- 
serum against human gamma globulin  was prepared in rabbits  by the Serology Section 
of the Central Laboratories,  New York Hospitai-Cornell  Medical Center.  The rabbit anti- 
human gamma globulin  serum was of high titer  and rcsldual  coagulant factors  were inac- 
tivated  by heating  at  60°C  for  5 minutes.  Human thrombin (human plasma thrombin, crude, 
Cutter Laboratories,  Berkeley)  and human fibrinogen  (Cutter  Laboratories)  were suspended 
in  isotonic  saline  solution.  Cepha~in was  prepared by the  method of  Bell  and Alton (5).  Stable 
product I  was  prepared  from  rabbit  instead  of  human blood reagents  according  to  the  method 
of Zucker-Franklin, Javid, and Spaet (6). 
Coagulation Studies.--The amount of platelet factor 3 activity available to the clotting 
process was determined by adding preformed product I and calcium to the test plasma and 
determining the clotting time of the mixture. The time required for coagulatiofl is referred 
to as the product I substrate time (3). 
Enumeration of platelets, the clotting time of whole blood in silicone-coated  glassware, 
the one-stage prothrombin time (Quick), a modified prothrombin time (Ware and Stragnell), 
fibrinogen content, activity of factors V and VII, and the plasma components of thrombo- 
plastin generation were determined by methods previously reported (7, 8). 
EXPER  rMlZNTAL 
The Effect  of Endotoxin  on Blood Coagulation in  Vitro.--McKay  and  asso- 
ciates (1) and Robbins and Stetson (2) have demonstrated that bacterial endo- 
toxin shortens  the coagulation time of whole blood in siliconized tubes or cit- 
rated  PRP  after  recalcificafion.  Coagulation  acceleration  was  considerably 
greater in PRP  than PPP, indicating that platelets were involved in the reac- H.  I.  HOROWITZ,  R.  M.  DES  PREZ,  AND  E.  W.  HOOK  621 
tion. As shown in Table I, these observations were readily confirmed. Whole 
blood to which had been added endotoxin in a concentration of 100/~g per ml 
clotted in approximately one-third the time necessary for coagulation of blood to 
which saline was added. In addition, PRP containing endotoxin in a concentra- 
tion of  100/~g  per  mi coagulated  135  seconds after recalcification, whereas 
coagulation of PRP  without endotoxin required  215  seconds. There was no 
difference in the coagulation time after recalcification of PPP containing endo- 
toxin or saline. 
The observation that platelets are required for coagulation acceleration in 
vitro strongly suggests that endotoxins act on the first stage of coagulation; 
T~LEI 
C~ta~Eff~ts~En~toxmon~ag~at~ 
Material added 
Saline 0.1 ml 
Endotoxin 100/~g/ml 
Cephalin 1:200 
Endotoxin 100 #g/ml and cephalin 
1:200 
Clotting time 
Whole blood 
m/n. 
34 
11 
12 
12 
Recalcified PRP 
$8C. 
215 
135 
110 
117 
Recalcified PPP 
>350 
>350 
109 
112 
Product I 
substrate time 
PRP* 
SeC. 
23.7 
9.9 
I0.0 
10.0 
* Assayed after 50 minutes' incubation  at 37°C. 
i.e.,  the generation of thromboplastin. This  thesis  is also  supported by two 
additional observations:  (a)  Endotoxin in a  concentration of 100/~g per  ml 
incubated at 37°C with PPP for 1, 5, 15, 30, or 60 minutes does not accelerate 
coagulation after recalcification, as compared to control PPP (Table II), and 
accordingly  does  not  demonstrate  direct  thromboplastic  activity.  (b)  A 
thrombin-like effect of endotoxin is excluded by the observation that a mixture 
of fibrinogen (3 mg per ml) and endotoxin (100/~g per ml) failed to coagulate 
during the course of incubation at 37°C for 24 hours. McKay,  Shapiro, and 
Shanberge (1)  also  concluded  that  endotoxins do not possess  properties  of 
preformed  thromboplastin  or  thrombin,  but  act  on  the  coagulation system 
prior to the combination of thromboplastin precursors. 
Analysis  of the Acceleration of Thromboplastin Generation Induced by Endo- 
toxin.--Thromboplastin  generation can be considered as involving two processes 
which interact at their completion. In one process,  a  number of coagulation 
factors (viii, IX, x, xI, and XlI) interact in the presence of calcium to form 
a soluble protein substance with potent coagulant activity termed product I by 
Bergsagel and Hougie (9). The formation of product I is accelerated by foreign 622  BACTERIAL  ENDOTOXIN  AND  RABBIT  PLATELETS.  II 
surfaces and by small amounts of thrombin (10). In the other process, blood 
platelets, which in the intact state do not exhibit procoagulant activity, are 
altered or damaged in such a way that platelet factor 3 becomes available for 
interaction with product I  (10). Blood thromboplastin is formed when product 
I  interacts with  available platelet factor 3  in  the presence of factor V  and 
calcium. 
The activity of platelet factor 3  available for the  dotting process can be 
quantitated  by the product  I  substrate  time  (see Materials  and  Methods). 
As shown in Table I, incubation of PRP with endotoxin greatly accelerates the 
product I  substrate  time. Addition of product I  and calcium to PRP which 
had been incubated with  endotoxin in  a  concentration of  100  #g per ml  at 
TABLE LI 
Absence of Surface-Activating Effect of Endotoxin 
Time of  incubation  (37°C) 
mln. 
1 
5 
15 
30 
6O 
Clotting time after recalcificatlon (sillconized glassware) 
PPP + endotoxln  PPP +  saline 
185.0 
177.0 
115.9 
106.3 
105.2 
100 Izg/ml 
$t~C. 
182.4 
180.7 
128.0 
111.8 
106.3 
PPP +  saline 
+  celite* 
$8$. 
65.1 
59.9 
58.2 
50.6 
51.7 
* Diatomaceous  silica, 5 mg per ml. 
37nc  for  1  hour resulted  in  clot formation in  9.9  seconds,  whereas  control 
plasma incubated with saline clotted in 23.7 seconds. Brain cephalin can be used 
as a substitute for platelet factor 3 in readily available form (5). Thus, it is of 
interest that cephalin accelerates the coagulation time of whole blood or recalci- 
fled plasma  to a  degree quite comparable to that produced by incubation of 
blood or PRP with endotoxin (Table I). The effects of cephalin and endotoxin 
are not additive. 
Although the above findings are consistent with the concept that the coagu- 
lation-accelerating effect of endotoxin is mediated by platelet damage which 
increases  the  availability of platelet factor 3  for interaction with  product I 
to form blood  thromboplastin,  these  observations do not  exclude the possi- 
bility  that  thromboplastin  generation  is  accelerated in  other  ways  as  well. 
Other possible mechanisms include (a) acceleration of product I  formation by 
endotoxin acting as a foreign surface, and (b) increase in the activity of other 
coagulation factors as an indirect effect of the interaction between endotoxin 
and platelets or plasma factors. These possibilities were investigated as follows: H. I. HOROWITZ,  R. M'. DES PREZ,  AND  E. W. HOOK  623 
(a). PPP prepared  from a single bleeding was divided into three  aliquots in siliconized 
glass tubes. Endotoxin in a concentration of 100 #g per ml of plasma was added to one tube 
and a control amount of saline was added to another. To the third specimen 5 mg per ml of 
diatomaceous silica, a substance known to effect maximum surface activation in coagulation 
systems (11), was added. The three specimens were incubated at 37°C, aliquots were removed 
at intervals, and the coagulation times after recalcification determined. 
A  moderate acceleration of the recalcificafion time was observed during the 
course of incubation (Table II) but no difference between the PPP containing 
endotoxin and the saline-treated control PPP was observed.  In contrast, the 
effect  of  surface  activation is  illustrated by the  appreciable coagulation ac- 
TABLE III 
Measurement of Other Coagulation Factors before and after Incubation of PRP or PPP 
with Endotoxin 
Coagulation  test 
Prothrombin time (Quick) 
Prothrombin time (Ware and 
Stragnell) 
Factor V 
Factor VII 
Plasma components of throm- 
boplastin generation 
Factors measured 
I, n, v, VII, X 
II, VII, X 
V 
VII 
V, VIII 
Clotting time after reealcification* 
PRP 
Endotoxin  Saline 
sec.  seG. 
6.4  6.7 
14.5  15.7 
11.9  12.4 
18.0  18.6 
6.0  5.9 
PPP 
Endotoxin 
sec. 
6.5 
i5.4 
11.8 
18.7 
5.6 
Saline 
sec. 
6.3 
14.3 
12.4 
18.4 
5.8 
* Incubated 60 minutes at 37°C and then centrifuged. 
celeration observed in the PPP containing diatomaceous silica. These findings 
make it unlikely that endotoxin has any direct surface-activating property on 
coagulation systems. 
(b) PRP or PPP was incubated with endotoxin in a concentration of 100 #g per ml. Con- 
trol plasmas were incubated with saline solution. Mter incubation at 37°C for 1 hour,  the 
specimens were centrifuged (to remove platelets  from PRP)  and the supernatant plasmas 
were employed in the coagulation tests indicated in Table HI. 
It is seen that exposure of either PRP or PPP to endotoxin did not increase 
the activity of prothrombin, factor V, factor VII, or the plasma components 
of thromboplastin generation as compared to the saline-incubated controls. 
Effects  of  Concentration  of  Endotoxin  and  Temperature  of  Incubation  on 
Platelet Factor 3  Activity  in  Vitro.--In  previous studies (3) it was shown that 
platelet  aggregation and release  of  platelet 5-hydroxytryptamine or  bacteri- 624  BACTERIAL ENDOTOXIN  AND  RABBIT  PLATELETS.  II 
cidins against Bacillus subtilis were strikingly influenced by dose of endotoxin 
and temperature  of incubation.  Enhancement  of platelet  factor 3  activity by 
endotoxin is also dose- and temperature-dependent. 
Aliquots of citrated PRP were mixed with endotoxin in concentrations of 0.1, 1.0, 10, and 
i00/~g per ml of plasma, and slowly rotated at 37°C. 0.1 ml aliquots of the endotoxin-plasma 
mixtures were removed immediately  after  addition  of endotoxin  and at varying intervals 
thereafter,  and immediately added to 0.2 ml of a stable product I--calcium chloride prepara- 
tion for determination  of product I substrate  time. 
As shown in Table  IV acceleration  of the product I  substrate  time varied 
directly with the dose of endotoxin and the duration of incubation. As little as 
1 #g per ml  of endotoxin consistently produced a  shortening of the product I 
TABLE IV 
Effect o] Dose of Endotoxin  on Product I  Substrate Time of Rabbit PRP 
Endotoxin 
~g/ml 
0 
0.1 
1.0 
10.0 
100 
* Mean 4- 
t,  <  o.ol. 
No. of 
animals 
10 
4 
4 
6 
10 
Time incubated 
rain.  30 min.  60 min.  I  120 min.  0 
Product I substxate time* 
$$~:, 
27.74-4.2 
26.0:::t::3.6 
26.04-3.6 
27.14-3.7 
27.84-4.2 
$¢C. 
26.14-3.9 
24.44-3.8 
22.04-2.8 
21.34-2.9 
15.9~4-2.7 
$$c, 
23.74-4.2 
22.2-4-2.4 
19.14-2.8 
15.5~4-2.3 
9.9~4-2.2 
SeG. 
22.84-4.5 
17.54-1.6 
14.74-1.9 
12.4~4-1.6 
10.6~4-1.8 
standard error. 
substrate  time, and 100 #g per ml of endotoxin produced maximal shortening, 
equal  in  magnitude  to  that  observed  after  addition  of  cephalin  in  optimal 
concentrations to entirely replace platelet factor 3. 
Aliquots of citrated  PKP were mixed with endotoxin in a concentration of 100 #g per ml 
and slowly rotated at 4  °, 25  °, and 37°C. Controls consisted of PRP incubated  with saline 
solution at each temperature.  One-tenth ml aliquots of the mixtures were removed immedi- 
ately and at intervals during incubation for determination of platelet factor 3 activity by the 
product I substrate  time. Ea~a sample was placed in a water bath at 37°C for 1 minute prior 
to testing. 
As shown in Table V, a  significant decrease in the product I  substrate  time 
occurred by 30 minutes after addition of endotoxin to PRP incubated at 37°C, 
and 60 minutes  of incubation produced  a  maximal  effect.  In contrast,  in the 
mixtures incubated at 25°C, no significant decrease in product I  substrate time 
was  observed  until  120  minutes  after  addition  of  endotoxin.  No  shortening H.  I.  HOROWITZ~ R.  M.  DES  PKEZ~ AND E.  W.  HOOK  625 
whatever of the product I  substrate time was apparent in the endotoxin-PRP 
mixtures incubated at 4°C. 
Activation  of  Platelet  Factor  3  by  Antigen-Antibody  Reactions  in  Vitro.-- 
Studies by Robbins and Stetson (2) demonstrated that the interaction of protein 
or polysaccharide antigens with specific  antibody in rabbit blood produced a 
marked  acceleration  of coagulation in  vitro  and  that platelets  were  required 
for this  effect.  The following experiment  suggests that  the effect of antigen- 
antibody interaction on coagulation results from activation of platelet factor 3. 
A 1:50 dilution of heat-inactivated rabbit anti-human gamma globulin serum was added 
to rabbit PRP containing varying concentrations of human gamma globulin. The mixtures 
TABLE V 
Effect of Temperature on Product I  Substrate Time of Rabbit PRP Incubated with Endotoxin 
Endc~ 
toxin 
I~g/ml 
0 
100 
0 
100 
0 
100 
No. of 
animals 
10 
10 
3 
3 
5 
5 
Tem- 
per- 
ature 
°C 
37 
37 
25 
25 
4 
4 
Incubation time 
Omin.  t  30rain.  ]  60rain.  120 rain. 
Product I substrate time* 
SSa. 
27.74-4.2 
27.8-4-4.2 
26.64-4.2 
26.64-4.2 
25.94-3.3 
26.04-3.3 
SeC. 
26.1:t:3.9 
15.9~4-2.7 
26.54-4.1 
25.74-4.2 
25.64-3.6 
25.24-3.5 
SCC, 
23.7-4-4.2 
9.9~4-2.2 
i  25.14-4.2 
i  21.64-2.6 
24.54-3.9 
23.64-3.5 
22.8-4-4.5 
lO.6~+1.8 
20.84-2.3 
15.o-4-1.3 
21.8±3.7 
21.3-4-2.8 
* Mean -4- 1 standard error. 
P  <  o.ol. 
were slowly rotated at 37°C as in previous experiments. Aliquots of each mixture were re- 
moved immediately and at intervals during incubation, and the product I substrate times 
determined. 
As shown in Table VI, the interaction of human gamma globulin and anti- 
body induced  an  increase  in  platelet  factor  3  activity  comparable  to  that 
produced by bacterial endotoxin in previous experiments. With the dilution of 
antiserum held at 1:50, optimal activation occurred after 60 minutes' incuba- 
tion with  0.1  or  1.0  #g per ml of gamma globulin.  Larger concentrations of 
gamma globulin were  less  effective than  smaller  doses,  suggesting a  prozone 
phenomenon as described by Robbins and Stetson (2)  in similar systems. 
A comparable increase in platelet factor 3 activity was observed after addi- 
tion of human gamma globulin to PRP from an animal previously immunized 
against human gamma globulin (Table VII). 
The Effect of Endotoxin  on Blood Coagulation  and  Platelet Factor 3  Activity 626  BACTERIAL  ENDOTOXIN  AND  RABBIT  PLATELETS.  II 
in Vivo.--McKay and Shapiro (12) demonstrated a marked decrease in whole 
blood clotting time in silicone 4 hours after injection of endotoxin in rabbits. 
The coagulation time had returned to normal values by 24 hours after injection. 
TABLE VI 
Effect of Antigen-Angbody Reaction on Product I  Substrate Time of Rabbit  PRP 
Antigen 
HGG 
b~g/ml 
0 
1.0 
0.1 
1.0 
10.0 
100.0 
Antibody 
(Coombs 
serum) 
dilution 
1:50 
0 
1:50 
1:50 
1:50 
1:50 
No. Of 
animals 
4 
4 
4 
4 
4 
4 
Incubation tlme 
0 rain.  30 min.  60 min.  120 min. 
Product I substrate time* 
36.84- 6.6 
41.5.4-6.6 
34.34-6.0 
34.74-6.6 
39.44-7.4 
37.7.4-6.3 
5eC. 
34.14-8.0 
36.54-3.9 
15.9~4-2.1 
16.44-2.8 
24.14-6.1 
30.2 -4-  5.2 
SeC. 
30.94-7.6 
30.64-2.6 
13.8~4-0.9 
13.2~4-1.4 
19.24-3.7 
23.74-3.4 
sec. 
27.4-4-5.6 
28.34-4-1.6 
14.8~-4-0.5 
14.3~:-4-1.5 
19.04- 3.6 
22.0-4-1.5 
* Mean 4- standard error. 
:~ P  <  O.Ol. 
TABLE VII 
Effect of Antigen on Product I  Substrate Time of PRP fiom Immunized Rabbit* 
Incubation time 
Human gamma globulin  0 min.  I  15 min.  30 rain.  45 min.  [  60 min.  90 min. 
Product I  substrate time 
~g/ml  sec.  sec.  $e¢.  se¢.  sec.  sec. 
0  33.3  33.8  30.2  27.7  25.6  21.1 
5  33.1  21.7  18.0  17.1  16.7  13.0 
50  28.8  18.6  17.7  13.2  14.0  14.2 
500  30.2  20.2  15.1  14.7  14.0  14.9 
* Rabbit received biweekly subcutaneous injections of human gamma globulin in adjuvant 
for 5 weeks prior to testing. 
In  the  following  studies  blood  coagulation  was  investigated  during  the  1st 
hour  after injection of endotoxin  in rabbits. 
Rabbits were prepared by insertion of an indwelling polyethylene catheter in the carotid 
artery. After recovery from anesthesia, baseline specimens of blood were obtained, and saline 
or endotoxin in doses  of 0.5,  1.0, or 5.0  mg was injected via the marginal ear vein. Serial 
specimens were withdrawn through the intra-arterial catheter at 1, 5, 15, 30, and 60 minutes 
after injection. PRP  and  PPP  were obtained  as previously mentioned,  and  all specimens 627 
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were kept at 4°C prior to testing. Each sample was assayed for whole blood dotting time 
(silicone),  platelet  count,  prothrombin time  (Quick,  and  Ware  and  Stragnell methods), 
fibrinogen content, and the product I substrate time using both PRP and PPP. 
The data from representative individual experiments are presented in Figs. 
1 to 4. The magnitude of the changes observed in repeated individual experi- 
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FIG.  1.  Changes in coagulation time after intravenous injection of endotoxin in graded 
doses into rabbits. Changes in this and subsequent figures are expressed  as per cent of pre- 
injection values. 
ments varied widely, but were consistent in direction. A significant shortening 
of the clotting time was observed at the higher dose level, was most pronounced 
at 1 to 5 minutes after injection, and returned to the control value after 1 hour 
(Fig. 1). Thrombocytopenia occurred at all dosage levels (Fig. 2). Mter injec- 
tion of 5.0  mg of  endotoxin, platelets decreased to  almost zero by 5  or  15 
minutes and were still depressed at 60 minutes after injection, Platelet factor 3 
activity as  measured by  the  product  I  time with  PRP  substrate  was  also 
maximally increased in the earliest specimens and returned to control values by 
1 hour (Fig. 3). 
The  finding  of  accelerated  coagulation  with  increased  platelet  factor  3 
activity  concurrent  with  marked  thrombocytopenia  can  be  interpreted  as 
indicating  either  that  the  few  remaining  platelets  were  more  active  than 
normal platelets or that platelet factor 3 had been released from aggregated 
and sequestered platelets and was present in plasma. The changes in product I 628  BACTERIAL ENDOTO~S~/ AND  IL~BBIT PLATELETS.  II 
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1~0. 2. Changes in platelet count alter intravenous injection of endotoxin in graded doses 
into rabbits. 
I00 
90 
8O 
70 
PRODUCT  Z  60 
SUBSTRATE  TIME 
PRP  50 
PER  CENT OF 
CONTROL  VALUE  40 
30 
20 
I0 
II---O  .... -------0  ............ O'  lu~ 
o----o  SALINE  CONTROL 
~  0,5 MG  ENDOTOXIN 
A.  , A  I.OMG  ENDOTOXlN 
0"~0  S.O M6  ENDOTOXIN 
OI  I ~  I 
o,  ~  ,s  3b  sb 
TIME  --  MINUTES 
FzG. 3. Changes in product T substrate time of PRP after intravenous injection of endo- 
toxin in graded doses into rabbits. H.  I.  HOROWITZ,  R.  M.  DES  PP.EZ,  AND  E.  W.  HOOK  629 
time with PPP substrate indicate that the latter appears to be the case (Fig. 
4).  These  changes  closely parallel  the  findings with  PRP,  indicating  that 
platelet factor 3 is transiently present in plasma apart from platelets following 
injection of endotoxin. 
No change was noted in fibrinogen concentration or in either of the pro- 
thrombin tests, indicating that appreciable intravascular coagulation did not 
occur. 
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FIO. 4. Changes  in product I substrate time of PPP after intravenous  injection  of endotoxin 
in graded doses into rabbits. 
DISCUSSION 
Previous studies (3)  have shown that bacterial endotoxins produce platelet 
aggregation and release of certain platelet factors. Platelet factor 3, a thrombo- 
plastin precursor, is present in platelets in a form not readily available to the 
clotting process (10,  13). The present studies, utilizing the product I substrate 
time as an assay of platelet factor 3  activity, suggest that endotoxin by an 
action on blood platelets in vitro or in ~vo increases the availability of platelet 
factor  3  for  thromboplastin  formation.  Moreover,  detailed  analysis  of  the 
effects of endotoxin on the coagulation mechanism in vitro has failed to demon- 
strate significant alteration in other coagulation factors. It seems likely that 
the action of endotoxin on platelets increasing the availability of platelet factor 
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This concept is further supported by observations that a comparable accelera- 
tion of coagulation can be achieved in vitro by thermal or mechanical disruption 
of platelets to increase the availability of platelet factor 3  (10,  13,  14),  or in 
v/~o by injection of phosphatides with platelet factor 3 activity (15,  16). 
Changes in blood coagulation after injection of endotoxin may play a crucial  role 
in the pathogenesis of the generalized  Shwartzman phenomenon (GSR). The GSR is 
classically produced by injection of two sublethal doses of endotoxin in rabbits within 
a  24  hour  period  and  is  characterized  by widespread  intravascular  deposition  of 
fibrinoid material particularly in glomerular capillaries and by bilateral renal cortical 
necrosis (17). The fibrinoid material appears to be derived from fibrinogen,  resembles 
fibrin in many respects, and may represent fibrin in a stage of partial polymerization 
(18). Although the initial or preparatory injection of endotoxin in rabbits apparently 
results in an increase in the level of fibrinogen by 24 hours after injection,  the second 
or provocative injection of endotoxin given 18 to 24 hours after the first is followed by 
marked decrease in circulating fibrinogen  (12). Defibrination and deposition of intra- 
vascular fibrinoid material occur at about the same time after injection of endotoxin, 
consistent with a  cause and effect relationship (12).  The observations that certain 
anticoagulants including heparin (19) and sodium warfarin (20) prevent deposition of 
intravascular fibrinoid  also implicate blood coagulation in the genesis of the GSR. 
Any explanation of the mechanism of the GSR must account for the requirement 
of two injections  of endotoxin spaced about 24 hours apart. Thomas has cited evi- 
dence  that the first dose of endotoxin impairs the function of the reticuloendothelial 
system, and has postulated that this impairment compromises the capacity to detoxify 
the second  dose, which  then circulates longer and reaches different  tissue  sites than 
the first dose (18). This hypothesis is consistent with the observation that the GSR can 
be produced after a single dose of endotoxin in animals pretreated with thorotrast, 
trypan blue, colloidal iron or carbon, or cortisone,  all of which substances may impair 
reficuloendothelial  function (18, 21, 22). 
A recent report by Lee has offered an hypothesis which integrates altered coagula- 
tion and depressed  reticuloendothelial  function in the pathogenesis of the GSR (23). 
Previous workers had noted that intravenous infusion of large doses of thromboplastin 
or thrombin, although initiating intravascular coagulation,  did not produce lesions 
typical of the GSR (24-26).  In these experiments thrombi appeared predominantly 
in the lungs and veins but not in the kidneys. Lee reasoned that an efficient mechanism 
exists for removing products of fibrin polymerization from the general circulation,  and 
investigated  the possibilities  of activation of proteolytic enzymes with  fibrinolytic 
activity, and removal of fibrin or fibrin intermediates from the circulation by reticulo- 
endothelial cells. Evidence of an active fibrinolytic mechanism in rabbits after injec- 
tion of endotoxin or thrombin could  not be obtained. However, it was possible  to 
demonstrate that thrombin, in doses which only occasionally  produced lesions of the 
GSR in normal animals, regularly induced  renal cortical necrosis and changes  typical 
of the GSR in rabbits in which reticuloendothelial  function had been depressed  by 
prior injections of thorotrast, denatured albumin, or endotoxin.  In these studies it was 
also observed that thorotrast given as long as 3 hours after endotoxin increased  the 
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cular events occurring subsequent to the disappearance of endotoxin from the circula- 
tion. As an explanation of these observations Lee proposed that the reticuloendothelial 
system of normal animals functions efficiently to remove fibrin polymers formed in the 
blood stream, that the first dose of endotoxin given to prepare for the GSR serves to 
depress reticuloendothelial function, and that fibrin formed after the second injection 
of endotoxin is accordingly  not cleared from the blood stream and is deposited as 
fibrinoid  in terminal vascular beds. 
Whether the reticuloendothelial  system plays a major role in the removal of fibrin 
or fibrinogen polymers from the blood stream has not yet been determined. However, 
recent observations by Spaet and associates (27) indicate that thromboplastin and 
thromboplastin precursors are cleared by the reticuloendothelial  system with sufficient 
avidity that injections of rather large quantities of these materials do not result in 
intravascular coagulation.  These authors believe that the clearance  of clotting inter- 
mediates by the reticuloendothelial  system is an important factor in the preservation 
of blood fluidity in vivo. Thus, in states characterized by alterations in the rate of 
formation or activation of thromboplastin or thromboplastin precursors the normal 
reticuloendothelial  system is competent to remove the proeoagulant substance and 
prevent thrombin formation and conversion of fibrinogen  to fibrin.  In this regard, 
Adelson  and associates (28) have demonstrated that hypercoagulable states accom- 
panying thrombus formation, operative procedures, and  epinephrine injection con- 
siderably modify the half-life  of labeled platelets but have no effect on the rate of 
utilization of labeled fibrinogen. 
The  rapid  disappearance  of  platelet  factor  3  activity  from  platelet-poor 
plasma of rabbits after injection of a single dose of endotoxin as demonstrated 
in the present studies raises the possibility that this factor, like thromboplastin, 
is removed from the blood stream by the reticuloendothelial system. If this is 
correct, depression of reticuloendothelial function might result in accumulation 
of  thromboplastin in  amounts  sufficient  to  initiate  widespread  intravascular 
coagulation. It is possible that in the pathogenesis of the GSR altered clearance 
by  the  reticuloendothelial  system of  thromboplastin  or  thromboplastin pre- 
cursors is as important as the altered clearance of fibrin postulated by Lee (23). 
The changes in  activity of platelet factor 3  appear to be an adequate  ex- 
planation  for the  changes in  coagulation  observed during  the  1st hour  after 
injection of endotoxin in rabbits, but are not necessarily related to the coagu- 
lation  acceleration  noted  by  McKay  and  Shapiro  4  hours  after  endotoxin 
injections (12). 
SUMMARY 
Incubation of rabbit platelet-rich plasma with bacterial endotoxin results in 
activation  of  platelet  factor  3,  a  precursor  of  blood  thromboplastin.  This 
platelet-endotoxin  interaction  is  dose-  and  temperature-dependent,  and  is 
similar  to  the  effects of antigen-antibody union  in  the presence of platelets. 
Injection of endotoxin intravenously is associated with a  transient increase in 632  :BACTERIAL ENDOTOY~II~ AND  RABBIT  PLATELETS. 11" 
platelet factor 3. Since platelet factor 3 can be demonstrated in platelet-poor 
plasma as well as platelet-rich plasma after endotoxin injection, it seems likely 
that an actual transfer of factor 3 from platelets to plasma  occurs and that 
this activity is then rapidly inactivated or cleared from the blood stream. 
The assistance of Miss Mitzu Fujimoto and Miss Aid Yamamoto is gratefully acknowl- 
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